Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.

BACKGROUND Adipose tissue is responsible for releasing various adipokines that have been related to insulin resistance. Understanding the relationship of these adipokines to insulin resistance may foster the development of new treatments for diabetes. OBJECTIVES The primary objective of this study was to determine whether an association between retinol-binding protein 4 (RBP4) and insulin resistance exists in nonobese individuals without a family history or diagnosis of diabetes. The secondary objective was to determine by a dual energy x-ray absorptiometry scan which adipose tissue depot most closely relates to RBP4 levels. DESIGN Cross-sectional analysis of 92 study participants ranging in age from 20 to 83 yr was performed. The range of body mass index (BMI) was from 18 to 30 kg/m(2). Exclusion criteria were a BMI greater than 30 kg/m(2), family history of diabetes, or a diagnosis of diabetes. Insulin sensitivity was determined by a hyperinsulinemic euglycemic clamp. Body fat was measured by dual energy x-ray absorptiometry scan. RESULTS RBP4 values were lower in females (35.8 +/- 1.7 microg/ml) compared with males (39.9 +/- 1.4 microg/ml; P = 0.06). RBP4 levels were found to correlate negatively with insulin sensitivity (r = -0.32; P = 0.002) and positively with age (r = 0.38; P < 0.001). RBP4 levels did not correlate with BMI (r = -0.13; P = 0.22), trunk fat (r = 0.16; P = 0.22), or percent body fat (r = 0.07; P = 0.65). However, RBP4 levels did correlate with percent trunk fat (r = 0.36; P = 0.001). CONCLUSION These findings indicate a relationship between RBP4, insulin sensitivity, and percent trunk fat in individuals who may not have features of insulin resistance.

[1]  K. Park,et al.  Plasma Retinol-Binding Protein-4 Concentrations Are Elevated in Human Subjects With Impaired Glucose Tolerance and Type 2 Diabetes , 2007, Diabetes Care.

[2]  Arya M. Sharma,et al.  Retinol-Binding Protein 4 in Human Obesity , 2006, Diabetes.

[3]  U. Smith,et al.  Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. , 2006, The New England journal of medicine.

[4]  Nimesh Mody,et al.  Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.

[5]  W. Garvey,et al.  Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M400373-JLR200 , 2005, Journal of Lipid Research.

[6]  Tamara B Harris,et al.  Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. , 2005, Archives of internal medicine.

[7]  S. Kritchevsky,et al.  Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study , 2005, Diabetologia.

[8]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[9]  D. Chinkes,et al.  Intramuscular and liver triglycerides are increased in the elderly. , 2004, The Journal of clinical endocrinology and metabolism.

[10]  M. Visser,et al.  Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. , 2004, Diabetes care.

[11]  Christopher J. Lyon,et al.  Minireview: adiposity, inflammation, and atherogenesis. , 2003, Endocrinology.

[12]  J. Flier,et al.  Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2. , 2003, Diabetes.

[13]  S. Kritchevsky,et al.  One- and two-year change in body composition as measured by DXA in a population-based cohort of older men and women. , 2003, Journal of applied physiology.

[14]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[15]  Xiao Man Yang,et al.  Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? , 2002, Diabetes.

[16]  Y. Matsuzawa,et al.  Serum adiponectin and leptin levels in patients with lipodystrophies , 2002 .

[17]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[18]  R. Steigbigel,et al.  Association of Severe Insulin Resistance With Both Loss of Limb Fat and Elevated Serum Tumor Necrosis Factor Receptor Levels in HIV Lipodystrophy , 2000, Journal of acquired immune deficiency syndromes.

[19]  P. Gouras,et al.  Impaired retinal function and vitamin A availability in mice lacking retinol‐binding protein , 1999, The EMBO journal.

[20]  J. Dickerson,et al.  Retinol, α-tocopherol and carotenoids in diabetes , 1999, European Journal of Clinical Nutrition.

[21]  N. Barzilai,et al.  Leptin selectively decreases visceral adiposity and enhances insulin action. , 1997, The Journal of clinical investigation.

[22]  M. Laakso,et al.  Insulin Action and Age: European Group for the Study of Insulin Resistance (EGIR) , 1996, Diabetes.

[23]  A. Goldberg,et al.  Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. , 1992, The Journal of clinical endocrinology and metabolism.

[24]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[25]  G. Paolisso,et al.  Age‐related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians , 2001, Diabetes/metabolism research and reviews.